Canopy Growth Corp vs Invesco DB Agriculture Fund — how do they compare? Canopy Growth Corp trades at $1.03 (market cap $421.10M), while Invesco DB Agriculture Fund trades at $27.83. The key difference: Invesco DB Agriculture Fund is trading nearer its 52-week high, Canopy Growth Corp nearer its low. Which is the better fit depends on your goals.
| CGC | DBA | |
|---|---|---|
Market Cap | $421.10M | — |
Sector | Health | — |
52-Week High | $1.92 | $28.73 |
52-Week Low | $0.86 | $25.44 |
Enterprise Value | $378.55M | — |
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $1.02, up 7.13% with a bullish technical signal. The company reported Q1 fiscal 2027 revenue growth of 13% to C$81.2 million and narrowed its EBITDA loss. While revenue trends show stabilization after declining from $520M in 2022 to $269M in 2025, the company continues to post significant net losses with a -222.36% margin. The balance sheet shows improvement with debt-to-asset ratio declining from 53.61% in 2023 to 33.13% in 2025.
CGC presents a high-risk opportunity with potential catalysts from cannabis rescheduling and European expansion. The stock trades below book value (P/B 0.86) but faces substantial execution risks amid persistent losses. Analyst sentiment is mixed with 33% buy ratings, reflecting optimism about restructuring progress versus concerns about profitability timeline.
DBA trades at $27.79, down slightly by 0.11% today, while technical indicators show a bullish trend with strong moving average support. The fund has gained 5% over the past month, outperforming the S&P 500, driven by positive momentum in agricultural commodities. Recent news highlights consolidation near all-time highs and a 3.25% yield, though key financial ratios like P/E and P/S are unavailable for this ETF.
The outlook remains positive due to agricultural commodity strength and geopolitical factors, but risks include sector volatility and management fees. Investor sentiment is bolstered by recent performance and analyst buy ratings, yet dependence on commodity prices and global supply shocks pose significant downside risks for stockholders.
Trailing returns across standard periods
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →The index, which is comprised of one or more underlying commodities ("index commodities"), is intended to reflect the agricultural sector. The fund pursues its investment objective by investing in a portfolio of exchange-traded futures.
Read more on DBA →